Pharmacological Inhibition and Activation of the Ca2+ Activated Cl− Channel TMEM16A

URN to cite this document:: urn:nbn:de:bvb:355-epub-431800
DOI to cite this document:: 10.5283/epub.43180

Centeio, Raquel ; Cabrita, Inês ; Benedetto, Roberta ; Talbi, Khaoula ; Ousingsawat, Jiraporn ; Schreiber, Rainer ; Sullivan, John K.

; Kunzelmann, Karl

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(7MB)

Date of publication of this fulltext: 12 May 2020 12:33

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

TMEM16A is a Ca2+ activated Cl- channel with important functions in airways, intestine, and other epithelial organs. Activation of TMEM16A is proposed as a therapy in cystic fibrosis (CF) to reinstall airway Cl- secretion and to enhance airway surface liquid (ASL). This CFTR-agnostic approach is thought to improve mucociliary clearance and lung function in CF. This could indeed improve ASL, ...